Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.45 GBX | +0.14% | -0.56% | +39.02% |
Apr. 10 | Futura Medical hails results as erectile dysfunction drug drives sales | AN |
Apr. 10 | Transcript : Futura Medical plc, 2023 Earnings Call, Apr 10, 2024 |
Sales 2023 | 3.1M 3.87M | Sales 2024 * | 9.52M 11.89M | Capitalization | 107M 133M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | -3 -3.75 | EV / Sales 2023 | 22.3 x |
Net cash position 2023 | 7.71M 9.64M | Net cash position 2024 * | 2.94M 3.68M | EV / Sales 2024 * | 10.9 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-34.8
x | Employees | 12 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 67.12% |
Latest transcript on Futura Medical plc
1 day | +0.14% | ||
1 week | -0.56% | ||
Current month | -12.47% | ||
1 month | -6.71% | ||
3 months | +17.00% | ||
6 months | +9.41% | ||
Current year | +39.02% |
Managers | Title | Age | Since |
---|---|---|---|
James Barder
CEO | Chief Executive Officer | - | 01-05-31 |
Angela Hildreth
DFI | Director of Finance/CFO | - | 18-02-19 |
Ken James
CTO | Chief Tech/Sci/R&D Officer | - | 16-03-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Needham
CHM | Chairman | 68 | 21-10-07 |
Gordon Davis
BRD | Director/Board Member | 67 | Jan. 08 |
James Barder
CEO | Chief Executive Officer | - | 01-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 35.45 | +0.14% | 246,675 |
24-04-25 | 35.4 | -1.12% | 241,540 |
24-04-24 | 35.8 | +0.70% | 253,853 |
24-04-23 | 35.55 | -0.14% | 350,597 |
24-04-22 | 35.6 | -0.14% | 204,772 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+39.02% | 133M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- FUM Stock